In this video, Motley Fool health-care analyst David Williamson discusses what investors should look for in Eli Lilly's upcoming earnings report, and what the big pharma has in store for 2013.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Foolish Preview: Eli Lilly Earnings
By Dave Williamson
–
Jan 28, 2013 at 8:06PM
NYSE: LLY
Eli Lilly
Market Cap
$723B
Today's Change
(-2.74%) -$21.54
Current Price
$763.49
Price as of June 20, 2025, 3:59 p.m. ET
What to expect for the big pharma's fourth quarter.
David Williamson has no position in any stocks mentioned. Follow him on Twitter: @MotleyDavid.
The Motley Fool recommends and owns shares of Johnson & Johnson. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
Eli Lilly
LLY
$763.49
(-2.74%)
$-21.54
Johnson & Johnson
JNJ
$149.81
(-0.61%)
$0.92
Celgene
CELG
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Eli Lilly Just Made Another Move to Dominate the Weight Loss Market: Should You Buy the Stock?
1 Growth Stock Down 9% to Buy Right Now
Down 12%, Should You Buy the Dip on Eli Lilly?
Should You Buy Eli Lilly Stock Before June 22?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.